Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-04-01

Clinical Trial Update: Transgender Youth and PrEP: PK, Safety, Uptake & Adherence - PK Study [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial update assessing pharmacokinetics, safety, uptake and adherence of PrEP in transgender youth.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Hektoen Institute for Medical Research | Conditions: HIV/AIDS, Gender | Phase 1, Phase 2 | Status: COMPLETED